NeuroXess
PrivateLast Round
Series A
Extension
Jul 7, 2026
Total Funding Raised
$15.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuroXess is a life sciences company that develops invasive brain-computer interface (BCI) technology, including flexible electrodes, medical equipment, and software, for medical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroXess Comparables
Compare NeuroXess with similar companies based on industry and business-model similarity.
NeuroXess Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 7, 2026 | ||||
| Series B | Sep 1, 2025 | ||||
| Series A | Dec 28, 2022 | ||||
| Seed | Jan 11, 2022 |
NeuroXess Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series A, Seed |
| Shanghai Sailing Capital | Series A |
| Zhongping Capital | Series A |
| Sequoia Capital | Seed |
| Yonghua Capital | Seed |
| Shanda Capital | Seed |
| Shanda Group | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 36, 720% of headcount.
- Jul 13, 2026
Open roles increased to 30, 600% of headcount.
Recent news
Latest coverage and updates
- is_developingJun 15, 2026
Neuroxess is developing NEO device on Jun 15th '26.
NeuroXess Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroXess's valuation, stock price, and market status.
Is NeuroXess a public or private company?
NeuroXess is a private company.
What is the current stock price of NeuroXess?
NeuroXess is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroXess worth (valuation)?
Valuation information for NeuroXess is not publicly available.
Can I buy NeuroXess stock?
NeuroXess shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroXess's last funding round?
NeuroXess's most recent funding round was Series A on December 28, 2022.
Who are the main investors in NeuroXess?
Key investors in NeuroXess include Zhongping Capital, Sequoia Capital, Shanda Capital.
Will NeuroXess IPO soon?
No public IPO plans have been announced for NeuroXess.
How can I track NeuroXess secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroXess's secondary market activity and sign up for updates.